KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Share-based Compensation (2016 - 2025)

Astrana Health's Share-based Compensation history spans 16 years, with the latest figure at $7.7 million for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 24.18% year-over-year to $7.7 million; the TTM value through Sep 2025 reached $42.5 million, up 51.55%, while the annual FY2024 figure was $34.5 million, 56.7% up from the prior year.
  • Share-based Compensation for Q3 2025 was $7.7 million at Astrana Health, down from $11.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $15.2 million in Q4 2024 and bottomed at $1.3 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $5.6 million (2022), against an average of $5.6 million.
  • The largest annual shift saw Share-based Compensation surged 193.7% in 2021 before it rose 7.47% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $2.4 million in 2021, then skyrocketed by 132.11% to $5.6 million in 2022, then surged by 54.27% to $8.7 million in 2023, then soared by 75.6% to $15.2 million in 2024, then crashed by 49.47% to $7.7 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Share-based Compensation are $7.7 million (Q3 2025), $11.7 million (Q2 2025), and $7.8 million (Q1 2025).